Agency Forms Undergoing Paperwork Reduction Act Review, 40065-40067 [2015-17011]
Download as PDF
Federal Register / Vol. 80, No. 133 / Monday, July 13, 2015 / Notices
withdrawal requests postmarked no
later than January 6, 2016. Comments
SUMMARY: EPA issued a notice in the
must be received on or before January 6,
Federal Register of June 10, 2015,
2016, for those clothianidin registrations
concerning amendments to terminate
where the 180–day comment period has
uses in certain pesticide registrations.
not been waived.’’
This document corrects errors in the
3. On page 32948, first column,
sections titled ‘‘DATES’’ and ‘‘What
paragraph two of Unit II is corrected to
action is the agency taking?’’.
read as follows:
FOR FURTHER INFORMATION CONTACT:
‘‘Unless a request is withdrawn by the
Ricardo Jones, Pesticide Re-evaluation
chloroxylenol registrant by July 10,
Division (7508P), Office of Pesticide
2015, EPA expects to issue orders
Programs, Environmental Protection
terminating the uses described in Table
Agency, 1200 Pennsylvania Ave. NW.,
1 of the June 10, 2015, document for the
Washington, DC 20460–0001; telephone active ingredient chloroxylenol. Users of
number: (703) 347–0493; email address: these pesticides or anyone else desiring
jones.ricardo@epa.gov.
the retention of a use should contact the
applicable registrant directly during this
SUPPLEMENTARY INFORMATION:
30–day period. Unless a request is
I. General Information
withdrawn by the clothianidin
registrant by January 6, 2016, EPA
A. Does this action apply to me?
expects to issue orders terminating the
The Agency included in the June 10,
uses described in Table 1 of the June 10,
2015, notice a list of those who may be
2015, document for the active ingredient
potentially affected by this action.
clothianidin. Users of these pesticides
B. How can I get copies of this document or anyone else desiring the retention of
and other related information?
a use should contact the applicable
registrant directly during this 180–day
The docket for this action, identified
period.’’
by docket identification (ID) number
Authority: 7 U.S.C. 136 et seq.
EPA–HQ–OPP–2015–0317, is available
at https://www.regulations.gov or at the
Dated: July 6, 2015.
Office of Pesticide Programs Regulatory
Michael Goodis,
Public Docket (OPP Docket) in the
Acting Director, Pesticide Re-Evaluation
Environmental Protection Agency
Division, Office of Pesticide Programs.
Docket Center (EPA/DC), West William
[FR Doc. 2015–17042 Filed 7–10–15; 8:45 am]
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW., Washington, DC BILLING CODE 6560–50–P
20460–0001. The Public Reading Room
is open from 8:30 a.m. to 4:30 p.m.,
Monday through Friday, excluding legal FEDERAL ELECTION COMMISSION
holidays. The telephone number for the
Sunshine Act Meetings
Public Reading Room is (202) 566–1744,
and the telephone number for the OPP
AGENCY: Federal Election Commission.
Docket is (703) 305–5805. Please review DATE & TIME: Thursday, July 16, 2015 at
the visitor instructions and additional
10:00 a.m.
information about the docket available
PLACE: 999 E Street NW., Washington,
at https://www.epa.gov/dockets.
DC (Ninth Floor).
II. What does this correction do?
STATUS: This meeting will be open to the
public.
The notice (FR Doc. 2015–14092)
ITEMS TO BE DISCUSSED:
published in the Federal Register of
Correction and Approval of Minutes for
June 10, 2015 (80 FR 32947) (FRL–
June 18, 2015
9928–01) is corrected as follows:
Draft Advisory Opinion 2015–02: Grand
1. On page 32947, second column,
Trunk Western Railroad Company—
under the heading ‘‘Dates’’, correct
Illinois Central Railroad Company
paragraph one to add: ‘‘chloroxylenol’’
PAC
before the word ‘‘registrations’’
Draft Advisory Opinion 2015–03:
wherever it appears.
2. On page 32947, second column,
Democracy Rules, Inc.
under the heading ‘‘Dates’’, after
Draft Advisory Opinion 2015–04:
paragraph one, correct to add a new
Collective Actions PAC
paragraph that reads as follows: ‘‘Unless Proposed Directive 74 on the Timely
a request is withdrawn by January 6,
Resolution of Enforcement Matters
2016, for clothianidin registrations for
Notice to Respondents of Information
which the registrant has not requested a
Sharing by the Commission
waiver of the 180–day comment period, Proposed Statement of Policy Regarding
EPA expects to issue orders terminating
the Public Disclosure of Closed
these uses. The Agency will consider
Enforcement Files
asabaliauskas on DSK5VPTVN1PROD with NOTICES
ACTION:
Notice; correction.
VerDate Sep<11>2014
19:27 Jul 10, 2015
Jkt 235001
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
40065
Policy on Third-Party Appearances
Before the Commission to Discuss
Advisory Opinions
Draft Notice of Disposition on REG
2014–06: Candidate Debates
Draft Notice of Availability on REG
2015–03: Contributions from
Corporations and Other Organizations
to Political Committees
Draft Notice of Availability on REG
2015–04: Independent Spending by
Corporations, Labor Organizations,
Foreign Nationals, and Certain
Political Committees
Revised Meeting Dates for September—
December 2015
Management and Administrative
Matters
Individuals who plan to attend and
require special assistance, such as sign
language interpretation or other
reasonable accommodations, should
contact Shawn Woodhead Werth,
Secretary and Clerk, at (202) 694–1040,
at least 72 hours prior to the meeting
date.
PERSON TO CONTACT FOR INFORMATION:
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
Shawn Woodhead Werth,
Secretary and Clerk of the Commission.
[FR Doc. 2015–17275 Filed 7–9–15; 4:15 pm]
BILLING CODE 6715–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
[30Day–15–15TG]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Agency for Toxic Substances and
Disease Registry (ATSDR) has submitted
the following information collection
request to the Office of Management and
Budget (OMB) for review and approval
in accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
E:\FR\FM\13JYN1.SGM
13JYN1
40066
Federal Register / Vol. 80, No. 133 / Monday, July 13, 2015 / Notices
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Promotion of the National ALS
Registry to Non-referral Centers—New—
Agency for Toxic Substances and
Disease Registry (ATSDR).
Background and Brief Description
ATSDR is requesting a two-year OMB
approval for the information collection
project entitled ‘‘Promotion of the
National ALS Registry to Non-referral
Centers’’. ATSDR is authorized by the
Public Health Law No: 110–373, ALS
Registry Act to (1) develop a system to
collect data on amyotrophic lateral
sclerosis (ALS) and other motor neuron
disorders that can be confused with
ALS, misdiagnosed as ALS, or progress
to ALS; and (2) establish a national
registry for the collection and storage of
such data to develop a population-based
registry of cases.
ATSDR implemented the National
ALS Registry (Registry) in 2009 using an
neurologists who do not work at major
ALS referral centers. The following
objectives are set for this project:
(1) To implement a pilot project to
conduct educational and promotional
outreach activities at non-referral center
neurology practices in the U.S., to
inform neurologists and their staff about
the Registry;
(2) To encourage neurologists to
inform their patients about the Registry,
and to increase persons with ALS selfenrollment in the Registry through the
web portal via the use of existing
Registry brochures, pamphlets, and
factsheets; and
(3) To examine the effectiveness of
educational and promotional outreach
activities by reviewing persons with
ALS self-enrollment rates before,
during, and after the project period.
By increasing self-enrollment rates,
ATSDR will be able to produce more
accurate estimates of prevalence of ALS,
and collect risk-factor survey data from
a more representative sample of persons
with ALS nationwide which will allow
ATSDR to fulfill its congressional
mandate under the ALS Registry Act.
To achieve these objectives, a four
group educational and promotional
outreach project respondents has been
designed.
Data for the study will be gathered by
means of initial eligibility phone calls
and follow-up phone calls and mailings,
for neurologists who do or would
diagnose/care for patients with ALS.
Train-the trainer sessions will be
conducted to educate neurologists about
the Registry and key informant
interviews with neurologists will be
done to better understand their
knowledge, attitudes, and beliefs about
the Registry, and to gather additional
information about the currently
deployed Registry materials.
Participation is voluntary. The total
annual burden hours for the proposed
project is 344. There is no cost to the
respondents other than their time.
algorithm applied to national
administrative databases. A selfregistration component was launched in
October 2010.
The primary goal of the Registry is to
obtain more complete information on
the likely prevalence of ALS and to
better describe the demographic
characteristics (age, race, sex, and
geographic location) of those with ALS.
The secondary goal of the registry is to
collect additional information on
potential risk factors for ALS including,
but not limited to, family history of
ALS, smoking history, and military
service.
The Registry’s case ascertainment
methodology required validation;
therefore, ATSDR established State and
Metropolitan ALS Surveillance Projects
(Surveillance Projects). In order to avoid
biasing results from the Surveillance
Projects’ evaluation of the Registry’s
completeness, staff were instructed to
not promote the Registry during the
surveillance period.
The proposed project is a new
component to be added to the existing
Registry and ALS Surveillance Projects
to increase self-enrollment rates of those
with ALS. According to the Morbidity
and Mortality Weekly Report (MMWR)
published in 2014, the proportion of
cases identified via self-registration was
lower than those identified in the
administrative data for the period
October 2010–December 2011. On-going
self-registration is critical because not
all persons with ALS can be identified
through the algorithm, and only selfregistering persons with ALS can
complete the risk-factor surveys.
Therefore, efforts to increase Registry
awareness among non-referral center
neurology practices/neurologists is
needed to increase self-enrollment of
persons with ALS.
This new information collection aims
to evaluate educational and promotional
outreach activities among select nonreferral/non-specialty center neurology
practices and is a result of the need to
promote the Registry among
ESTIMATED ANNUALIZED BURDEN HOURS
Number of respondents
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Type of respondents
Form name
Neurologist Support Staff ...............................
Neurologist Support Staff ...............................
Neurologist Support Staff ...............................
Number of responses per
respondent
1,900
380
950
1
1
1
6/60
1/60
3/60
950
1
3/60
190
60
64
21
1
1
1
1
1/60
6/60
6/60
1
Initial Phone Call ............................................
Fax to Determine Provider Status ..................
Follow-up Phone Call 1 (One-Week Post
Mailing).
Follow-up Phone Call 2 (Three Months Post
Mailing).
Fax to Determine if Mailing was Received ....
Train-the-trainer Invitation Phone Call ...........
Key Informant Interview Invitation Phone Call
Train-the-trainer ..............................................
Neurologist Support Staff ...............................
Neurologist Support Staff ...............................
Neurologist/Neurologist Support Staff ............
Neurologist/Neurologist Support Staff ............
Neurologist/Neurologist Support Staff ............
VerDate Sep<11>2014
19:27 Jul 10, 2015
Jkt 235001
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
E:\FR\FM\13JYN1.SGM
13JYN1
Avg. burden
per response
(in hrs.)
40067
Federal Register / Vol. 80, No. 133 / Monday, July 13, 2015 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of respondents
Type of respondents
Form name
Neurologist ......................................................
16
1
Key Informant Interview .................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–17011 Filed 7–10–15; 8:45 am]
BILLING CODE 4163–18–P
[60Day–15–0920–0573; Docket No. CDC–
2015–0054]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed revisions of the
National HIV Surveillance System
(NHSS) information collection. This
data collection provides the primary
population-based data used to describe
the epidemiology of HIV in the United
States.
DATES: Written comments must be
received on or before September 11,
2015.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2015–
0054 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
VerDate Sep<11>2014
19:27 Jul 10, 2015
Jkt 235001
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
FOR FURTHER INFORMATION CONTACT:
Centers for Disease Control and
Prevention
SUMMARY:
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Number of responses per
respondent
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Avg. burden
per response
(in hrs.)
1
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
National HIV Surveillance System
(NHSS) (OMB Control No. 0920–0573,
Expiration 02/29/2016)—Revision—
National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CDC is authorized under Sections 304
and 306 of the Public Health Service Act
(42 U.S.C. 242b and 242k) to collect
information on cases of human
immunodeficiency virus (HIV) and
indicators of HIV disease and HIV
disease progression including AIDS.
Data collected as part of the National
HIV Surveillance System (NHSS) are the
primary data used to monitor the extent
and characteristics of the HIV burden in
the United States. HIV surveillance data
are used to describe trends in HIV
incidence and prevalence and
characteristics of infected persons. HIV
surveillance data are used widely at the
federal, state, and local levels for
planning and evaluating prevention
programs and health-care services, and
allocate funding for prevention and
care.
As science, technology, and our
understanding of HIV have evolved, the
NHSS has been updated periodically.
CDC, in collaboration with health
departments in the 50 states, the District
of Columbia, and U.S. dependent areas,
conducts national surveillance for cases
of HIV infection that includes critical
data across the spectrum of HIV disease
E:\FR\FM\13JYN1.SGM
13JYN1
Agencies
[Federal Register Volume 80, Number 133 (Monday, July 13, 2015)]
[Notices]
[Pages 40065-40067]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-17011]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Toxic Substances and Disease Registry
[30Day-15-15TG]
Agency Forms Undergoing Paperwork Reduction Act Review
The Agency for Toxic Substances and Disease Registry (ATSDR) has
submitted the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
[[Page 40066]]
burden of the proposed collection of information, including the
validity of the methodology and assumptions used; (c) Enhance the
quality, utility, and clarity of the information to be collected; (d)
Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses; and (e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Promotion of the National ALS Registry to Non-referral Centers--
New--Agency for Toxic Substances and Disease Registry (ATSDR).
Background and Brief Description
ATSDR is requesting a two-year OMB approval for the information
collection project entitled ``Promotion of the National ALS Registry to
Non-referral Centers''. ATSDR is authorized by the Public Health Law
No: 110-373, ALS Registry Act to (1) develop a system to collect data
on amyotrophic lateral sclerosis (ALS) and other motor neuron disorders
that can be confused with ALS, misdiagnosed as ALS, or progress to ALS;
and (2) establish a national registry for the collection and storage of
such data to develop a population-based registry of cases.
ATSDR implemented the National ALS Registry (Registry) in 2009
using an algorithm applied to national administrative databases. A
self-registration component was launched in October 2010.
The primary goal of the Registry is to obtain more complete
information on the likely prevalence of ALS and to better describe the
demographic characteristics (age, race, sex, and geographic location)
of those with ALS. The secondary goal of the registry is to collect
additional information on potential risk factors for ALS including, but
not limited to, family history of ALS, smoking history, and military
service.
The Registry's case ascertainment methodology required validation;
therefore, ATSDR established State and Metropolitan ALS Surveillance
Projects (Surveillance Projects). In order to avoid biasing results
from the Surveillance Projects' evaluation of the Registry's
completeness, staff were instructed to not promote the Registry during
the surveillance period.
The proposed project is a new component to be added to the existing
Registry and ALS Surveillance Projects to increase self-enrollment
rates of those with ALS. According to the Morbidity and Mortality
Weekly Report (MMWR) published in 2014, the proportion of cases
identified via self-registration was lower than those identified in the
administrative data for the period October 2010-December 2011. On-going
self-registration is critical because not all persons with ALS can be
identified through the algorithm, and only self-registering persons
with ALS can complete the risk-factor surveys. Therefore, efforts to
increase Registry awareness among non-referral center neurology
practices/neurologists is needed to increase self-enrollment of persons
with ALS.
This new information collection aims to evaluate educational and
promotional outreach activities among select non-referral/non-specialty
center neurology practices and is a result of the need to promote the
Registry among neurologists who do not work at major ALS referral
centers. The following objectives are set for this project:
(1) To implement a pilot project to conduct educational and
promotional outreach activities at non-referral center neurology
practices in the U.S., to inform neurologists and their staff about the
Registry;
(2) To encourage neurologists to inform their patients about the
Registry, and to increase persons with ALS self-enrollment in the
Registry through the web portal via the use of existing Registry
brochures, pamphlets, and factsheets; and
(3) To examine the effectiveness of educational and promotional
outreach activities by reviewing persons with ALS self-enrollment rates
before, during, and after the project period.
By increasing self-enrollment rates, ATSDR will be able to produce
more accurate estimates of prevalence of ALS, and collect risk-factor
survey data from a more representative sample of persons with ALS
nationwide which will allow ATSDR to fulfill its congressional mandate
under the ALS Registry Act.
To achieve these objectives, a four group educational and
promotional outreach project respondents has been designed.
Data for the study will be gathered by means of initial eligibility
phone calls and follow-up phone calls and mailings, for neurologists
who do or would diagnose/care for patients with ALS. Train-the trainer
sessions will be conducted to educate neurologists about the Registry
and key informant interviews with neurologists will be done to better
understand their knowledge, attitudes, and beliefs about the Registry,
and to gather additional information about the currently deployed
Registry materials.
Participation is voluntary. The total annual burden hours for the
proposed project is 344. There is no cost to the respondents other than
their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hrs.)
----------------------------------------------------------------------------------------------------------------
Neurologist Support Staff............. Initial Phone Call...... 1,900 1 6/60
Neurologist Support Staff............. Fax to Determine 380 1 1/60
Provider Status.
Neurologist Support Staff............. Follow-up Phone Call 1 950 1 3/60
(One-Week Post Mailing).
Neurologist Support Staff............. Follow-up Phone Call 2 950 1 3/60
(Three Months Post
Mailing).
Neurologist Support Staff............. Fax to Determine if 190 1 1/60
Mailing was Received.
Neurologist/Neurologist Support Staff. Train-the-trainer 60 1 6/60
Invitation Phone Call.
Neurologist/Neurologist Support Staff. Key Informant Interview 64 1 6/60
Invitation Phone Call.
Neurologist/Neurologist Support Staff. Train-the-trainer....... 21 1 1
[[Page 40067]]
Neurologist........................... Key Informant Interview. 16 1 1
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-17011 Filed 7-10-15; 8:45 am]
BILLING CODE 4163-18-P